AFT secures Russia deal

摘要

AFT Pharmaceuticals’ Maxigesic analgesic will soon be available in Russia, after the New Zealand-based firm signed a licensing agreement with local player Nearmedic. Under the terms of the deal, Nearmedic will commercialise in Russia tablet, oral liquid, hot drink, fastdissolve and dry powder sachet versions of Maxigesic, 'a patented, fixed combination' of ibuprofen and paracetamol.